Pharmacokinetics of budesonide controlled ileal release capsules in children and adults with active Crohn's disease

Abstract

The systemic exposure, systemic availability and cortisol suppression after oral administration of 9 mg budesonide were similar in children and adults with active Crohn's disease. Budesonide was well tolerated and no clinically important safety-related findings were identified.